ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
French researchers have discovered potent painkilling peptides from an unlikely source—the venom of black mamba snakes (Nature, DOI: 10.1038/nature11494). The peptides, which relieve pain in mice as powerfully as morphine does, act by a mechanism different from that of available painkillers. The discovery could help researchers expand the legions of painkillers, which currently rely heavily on opioids that carry side effects and potential for abuse.
Sylvie Diochot, Anne Baron, and colleagues at the Institute of Molecular & Cellular Pharmacology near Nice isolated the peptides, which they named mambalgins. The mambalgins appeal as leads for pain drugs because, unlike morphine, they don’t cause respiratory complications, Baron says.
Through studies using knockout mice, her team found that the peptides relieve pain by blocking acid-sensing ion channels in the skin and central nervous system. Although scientists have known that this family of channels plays a role in pain pathways, Baron says, none of the specific channels blocked by mambalgins has been associated with pain before.
The mambalgins also act on human acid-sensing ion channels, Baron says, which suggests that they may represent good candidates for drug development. However, peptide drugs usually cannot be taken orally because they fall apart in the presence of the digestive tract’s proteases. A small-molecule drug that inhibits the channels, although challenging to develop, would be a good alternative to peptides, she says.
“What’s really important is to diversify our portfolio of painkilling compounds,” says Yves De Koninck, director of the Division of Cellular & Molecular Neuroscience at the Québec Mental Health Institute. He says the dissimilarity of the mechanism of action of the mambalgins to that of morphine makes the compounds promising. “Let’s hope they translate into a therapeutic drug,” he says.
Most toxins in animal venoms cause pain rather than relieve it. What might the deadly mamba use mambalgins for? “If they’re relieving pain,” De Koninck suggests, “they may give time for other toxins to do their job, making the victim less worried.”
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on X